TY  - JOUR
AU  - Spelman, Tim
AU  - Meyniel, Claire
AU  - Rojas, Juan Ignacio
AU  - Lugaresi, Alessandra
AU  - Izquierdo, Guillermo
AU  - Grand'Maison, Francois
AU  - Boz, Cavit
AU  - Alroughani, Raed
AU  - Havrdova, Eva
AU  - Horakova, Dana
AU  - Iuliano, Gerardo
AU  - Duquette, Pierre
AU  - Terzi, Murat
AU  - Grammond, Pierre
AU  - Hupperts, Raymond
AU  - Lechner-Scott, Jeannette
AU  - Oreja-Guevara, Celia
AU  - Pucci, Eugenio
AU  - Verheul, Freek
AU  - Fiol, Marcela
AU  - Van Pesch, Vincent
AU  - Cristiano, Edgardo
AU  - Petersen, Thor
AU  - Moore, Fraser
AU  - Kalincik, Tomas
AU  - Jokubaitis, Vilija
AU  - Trojano, Maria
AU  - Butzkueven, Helmut
AU  - MSBasis (an MSBase Substudy) Investigators
PY  - 2016
DO  - 10.1177/1352458516679893
UR  - https://hdl.handle.net/10668/27691
T2  - Multiple sclerosis (Houndmills, Basingstoke, England)
AB  - Characteristics at clinically isolated syndrome (CIS) examination assist in identification of patient at highest risk of early second attack and could benefit the most from early disease-modifying drugs (DMDs). To examine determinants of second attack...
LA  - en
KW  - CIS
KW  - CSF
KW  - MRI
KW  - MS
KW  - Nomogram
KW  - clinically definite multiple sclerosis
KW  - clinically isolated syndrome
KW  - disease-modifying drugs
KW  - second attack
KW  - Adult
KW  - Age of Onset
KW  - Demyelinating Diseases
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Male
KW  - Middle Aged
KW  - Multiple Sclerosis
KW  - Nomograms
KW  - Prognosis
KW  - Proportional Hazards Models
KW  - Recurrence
KW  - Risk Factors
TI  - Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.
TY  - research article
VL  - 23
ER  -